• Exchange: EN Paris
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

VIRP:FP

166.7500 EUR 0.3000 0.18%

As of 11:35:00 ET on 04/17/2014.

Snapshot for Virbac SA (VIRP)

Open: 167.5500 Day's Range: 164.0000 - 167.5500 Volume: 3,581
Previous Close: 167.0500 52wk Range: 136.2000 - 184.1000 1-Yr Rtn: +10.69%

Stock Chart for VIRP

No chart data available.
  • VIRP:FP 166.7500
  • 1D
  • 1M
  • 1Y
167.0500
Interactive VIRP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VIRP

Current P/E Ratio (ttm) 23.3119
Estimated P/E(12/2014) 21.8031
Relative P/E vs. CAC 0.9156
Earnings Per Share (EUR) (ttm) 7.1530
Est. EPS (EUR) (12/2014) 7.6480
Est. PEG Ratio -
Market Cap (M EUR) 1,410.37
Shares Outstanding (M) 8.46
30 Day Average Volume 5,236
Price/Book (mrq) 4.0064
Price/Sale (ttm) 1.9159
Dividend Indicated Gross Yield 1.14%
Cash Dividend (EUR) 1.9000
Dividend Ex-Date 06/20/2014
5 Year Dividend Growth 11.55%
Next Earnings Announcement 08/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VIRP

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for VIRP

Virbac SA manufactures antibiotics, worm medicines, and vaccines for veterinary use. The Company's products are distributed in the United States, Europe, Asia and South America.

Eric MareeChairman-Mgmt BoardMichel GaraudetChief Financial Officer
Pierre PagesChief Operating OfficerChristian KarstExec VP:Corporate Dev
More Company Profile & Key Executives for VIRP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil